Chemed Co. (NYSE:CHE) Shares Acquired by Park Place Capital Corp

Park Place Capital Corp raised its position in shares of Chemed Co. (NYSE:CHE) by 33.4% in the fourth quarter, HoldingsChannel reports. The firm owned 2,086 shares of the company’s stock after acquiring an additional 522 shares during the period. Park Place Capital Corp’s holdings in Chemed were worth $1,105,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Fort Washington Investment Advisors Inc. OH boosted its stake in Chemed by 36.9% during the 4th quarter. Fort Washington Investment Advisors Inc. OH now owns 40,898 shares of the company’s stock valued at $21,668,000 after purchasing an additional 11,020 shares during the period. Mitchell & Pahl Private Wealth LLC boosted its stake in Chemed by 10.5% during the 4th quarter. Mitchell & Pahl Private Wealth LLC now owns 1,198 shares of the company’s stock valued at $635,000 after purchasing an additional 114 shares during the period. Ballentine Partners LLC lifted its stake in shares of Chemed by 7.5% in the 4th quarter. Ballentine Partners LLC now owns 704 shares of the company’s stock worth $373,000 after acquiring an additional 49 shares during the period. UMB Bank n.a. lifted its stake in shares of Chemed by 300.0% in the 4th quarter. UMB Bank n.a. now owns 52 shares of the company’s stock worth $28,000 after acquiring an additional 39 shares during the period. Finally, Smith Salley Wealth Management lifted its stake in shares of Chemed by 1.8% in the 4th quarter. Smith Salley Wealth Management now owns 16,988 shares of the company’s stock worth $9,000,000 after acquiring an additional 307 shares during the period. 95.85% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

CHE has been the subject of a number of research analyst reports. Royal Bank of Canada reduced their price target on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research note on Tuesday, November 5th. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a research note on Saturday, November 30th.

Insider Buying and Selling at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $572.77, for a total value of $1,145,540.00. Following the completion of the sale, the chief executive officer now directly owns 101,735 shares of the company’s stock, valued at $58,270,755.95. The trade was a 1.93 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, VP Brian C. Judkins bought 145 shares of the firm’s stock in a transaction on Monday, December 30th. The stock was acquired at an average cost of $519.50 per share, with a total value of $75,327.50. Following the completion of the transaction, the vice president now directly owns 1,678 shares of the company’s stock, valued at approximately $871,721. This represents a 9.46 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 3.32% of the company’s stock.

Chemed Price Performance

NYSE CHE opened at $557.49 on Wednesday. The company’s 50 day simple moving average is $545.05 and its 200 day simple moving average is $563.07. Chemed Co. has a 12 month low of $512.12 and a 12 month high of $654.62. The company has a market capitalization of $8.39 billion, a P/E ratio of 28.28, a PEG ratio of 2.16 and a beta of 0.47.

Chemed (NYSE:CHE) last released its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). Chemed had a net margin of 12.69% and a return on equity of 27.86%. The firm had revenue of $606.18 million for the quarter, compared to analyst estimates of $612.22 million. During the same quarter in the prior year, the firm earned $5.32 EPS. The firm’s revenue was up 7.4% compared to the same quarter last year. On average, analysts anticipate that Chemed Co. will post 21.43 earnings per share for the current year.

Chemed Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Monday, November 18th were paid a $0.50 dividend. The ex-dividend date was Monday, November 18th. This represents a $2.00 annualized dividend and a yield of 0.36%. Chemed’s dividend payout ratio is presently 10.11%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.